Pyridoclax-loaded nanoemulsion for enhanced anticancer effect on ovarian cancer-Reference-Cited by-同舟云学术

Pyridoclax-loaded nanoemulsion for enhanced anticancer effect on ovarian cancer

Published:2020-09 Issue: Volume:587 Page:119655
ISSN:0378-5173
Container-title:International Journal of Pharmaceutics
language:en
Short-container-title:International Journal of Pharmaceutics

Author:

Groo A.C.,Hedir S.,Since M.,Brotin E.,Weiswald L.-B.,Paysant H.,Nee G.,Coolzaet M.,Goux D.,Delépée R.,Freret T.,Poulain L.,Voisin-Chiret A.S.,Malzert-Fréon A.

Funder

Cancéropôle Grand Ouest

European Regional Development Fund

Publisher

Elsevier BV

Subject

Pharmaceutical Science

Reference48 articles.

1. A theoretical basis for a biopharmaceutic drug classification: the correlation of in vitro drug product dissolution and in vivo bioavailability;Amidon;Pharm. Res.,1995

2. PAMPA—critical factors for better predictions of absorption;Avdeef;J. Pharm. Sci.,2007

3. Rational formulation strategy from drug discovery profiling to human proof of concept;Ayad;Drug Deliv.,2015

4. Cellular uptake of nanoparticles: journey inside the cell;Behzadi;Chem. Soc. Rev.,2017

5. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries;Bray;CA Cancer J. Clin.,2018

Cited by 17 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Unraveling the multifaceted role of nanoemulsions as drug delivery system for the management of cancer;Journal of Drug Delivery Science and Technology;2024-10

2. Overview of BH3 mimetics in ovarian cancer;Cancer Treatment Reviews;2024-09

3. Revolutionizing nanomedicine: Expanding horizons of nanoemulsions in drug delivery and beyond;Journal of Dispersion Science and Technology;2024-06-20

4. Biomacromolecular carriers based hydrophobic natural products for potential cancer therapy;International Journal of Biological Macromolecules;2024-06

5. D-Optimal Mixture Design Enabled Development of Lyophilized Nanoemulsifying Drug Delivery System of Paliperidone;Drug Delivery Letters;2024-06